Name: |
ADENOSINE (AdenocardR) |
Classification: |
Antiarrhythmic:
- Produces short acting AV block to aid in the diagnosis of supraventricular tachycardias
- Drug of choice for acute conversion of SVT (all ages).
|
Dose: |
Bolus Dose:
- Administer each dose into a port as close to the patient as possible.
- Administer each dose undiluted by IV direct. Administer within 1-2 seconds.
- After each IV direct dose, administer a 20 mL sodium chloride 0.9% flush. Administer the flush as quickly as possible.
First dose:
6 mg IV direct by rapid bolus
Second dose if no response within 1-2 minutes:
12 mg IV direct by rapid bolus
Third dose if no response within 1-2 minutes:
12 mg IV direct by rapid bolus
Maximum total dose of 30 mg.
|
Administration: |
IV Infusion:
|
Contraindications: |
- Atrial flutter or fibrillation
- Ventricular tachycardia
- Known bronchospastic/bronchoconstrictive diseases (e.g. asthma)
- Symptomatic bradycardia, sick sinus syndrome, second or complete AV block (unless a functioning pacemaker)
|
Adverse Effects: |
- cardiovascular
- Symptoms associated with brief ventricular standstill (lightheaded, hypotension, flushing, nausea)
- Sinus bradycardia, sinus arrest, atrial fibrillation, AV block (usually < 1 minute)
- non-cardiovascular
- Metallic taste
- Blurred vision
- Dyspnea, shortness of breath, hyperventilation, bronchospasm
|
Drug Interactions: |
- adenosine + aminophylline/theophylline = decreased adenosine effect
- adenosine + digoxin = bradycardias and increased AV blocks
- adenosine + verapamil = bradycardias and increased AV blocks
- adenosine + beta blockers = bradycardias and increased AV blocks
|
Monitoring Therapy: |
- Continuous heart rate and cardiac rhythm
- Blood pressure
|
Adult Critical Care Protocol: |
- May be administered IV direct by an Adult Critical Care Nurse.
- A physician must be present during administration.
- This drug must be given by rapid IV direct bolus with immediate flush.
- Resuscitation equipment must be available.
|